Investigator Spotlight

Post Date: 
2020-12-01
Source: 
ACTG

Dr. Vidya Mave is Leader and Director of Byramjee-Jeejeebhoy Government Medical College-Johns Hopkins University (BJGMC-JHU) CRS based in Pune, India, where she oversees all clinical research activities for the CRS. This includes phase 1, 2, and 3 clinical trials of therapeutic drug interventions for HIV and co-morbid infections, including TB in adults (including pregnant women), adolescents and children. She is an Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine.
 
Dr. Mave has nearly 18 years of experience in clinical practice, education, and research in infectious diseases. She serves as a member of the ACTG TB transformative science group and cross-network TB vaccine working group. She is the current co-Chair of A5384, a phase 2 trial in planning phase aiming to optimize regimens for TB meningitis, a disease with high morbidity and mortality. She is also vice-Chair of A5397, a planning phase trial, which proposes to assess the ID 93 TB vaccine as a potential therapeutic vaccine. She is lead investigator for a phase 2/3 clinical trial on the efficacy and safety of VPM 1002, a recombinant BCG vaccine, to prevent TB recurrence, and she directs a large observational cohort in Pune investigating the epidemiology of HIV in India. She served as Chair of the Common Protocol for the Regional Prospective Observational Research in Tuberculosis (RePORT) India Consortium, a collaboration among six Indian and U.S. research/teaching institutions that is part of an international effort to identify and validate biomarkers that predict TB treatment outcomes and progression from latent infection to active disease.
 
Dr. Mave participated in two World Health Organization workshops that formulated guidelines on HIV vertical transmission management and TB clinical trial designs, respectively. In addition, Dr. Mave has mentored 20 pre- and post-doctoral trainees from India and Johns Hopkins, as well as trainees participating in the BJGMC-JHU HIV-TB Fogarty Research Training Program. She is an author of more than 100 peer-reviewed publications.
 
Dr. Mave received an M.D. in medicine from Karnatak University, Dharwad, India, and an M.P.H. from Tulane University. She completed her internal medicine training at St. Barnabas Hospital in New York, followed by a post-doctoral fellowship in infectious diseases at Tulane University and Long Island Jewish Medical Center.